Evotec SE (XBUL:EVT)
лв 8.815 0 (0%) Market Cap: 2.98 Bil Enterprise Value: 3.16 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 66/100

Q3 2023 Evotec SE Earnings Call Transcript

Nov 08, 2023 / 01:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Evotec SE Quarterly Statement 9 Months 2023. (Operator Instructions)

I would now like to turn the conference over to Dr. Werner Lanthaler, CEO. Please go ahead.

Werner Lanthaler
Evotec SE - Chairman of Management Board & CEO

Thank you. Good morning. Good afternoon. Welcome to our Q3 call. Resilient into the Future of Biopharma R&D, that's how we titled this presentation, which we have uploaded to the Internet and you are welcome to join this call also with the presentation. Resilience is all about being able to overcome the unexpected. Our goal of resilience is to follow science and technology and thrive together with our partners. So, you will see throughout this presentation that resilience is not what happens to you. Resilience for us is how you react to something, how you respond to something and how you recover from what happens to you.

I'm here together with my team, which you see on Slide #3 of this presentation with Laetitia, with Matthias

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot